Company Description
Anew Health is a Hong Kong-based pain management and health services provider with over 16 years of experience in pain management and functional enhancement, under our “ANKH” brand.
We offer a broad range of non-surgical, non-invasive, and non-pharmacological pain management treatment and therapies, functional enhancement therapies, and topical use and dietary supplements health products, to our clients to eliminate pain points, invigorate blood circulation, enhance the body’s detoxification function, strengthen muscle and joint, and ultimately enhance functionality.
We provide our pain management and function enhancement services in three service centers that are situated in prime commercial buildings in Hong Kong, and exquisitely renovated to provide an exclusive experience for our valued clients.
Apart from our pain management treatment services, we offer various types of Over-the-Counter topical use products, including creams, moisturizers, ointments, and dietary supplement products at our service centers and online shop on our website.
| Country | Hong Kong |
| Founded | 2007 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 220 |
| CEO | Mr. Ka Wai Victor, MO |
Contact Details
Address: Unit 2301-05, 23/F, Tower 5, The Gateway, Harbour City, 15 Canton Road Tsim Sha Tsui, Kowloon Hong Kong | |
| Phone | +852 3845 5012 |
| Website | ankh.com.hk |
Stock Details
| Ticker Symbol | AVG |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0002019042 |
| SIC Code | 8000 |
Key Executives
| Name | Position |
|---|---|
| Mr. Ka Wai Victor, MO | Director, Chief Executive Officer, and the Chairman of the Board |
| Ms. Sum Lok, CHEUNG | Director and Chief Operating Officer |
| Mr. Chin Wan, YEUNG | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 31, 2025 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Mar 7, 2025 | F-1 | Registration statement for certain foreign private issuers |
| Dec 20, 2024 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Nov 8, 2024 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Jun 21, 2024 | DRS | [Cover] Draft Registration Statement |